Holen Sie sich die Stockscreener-App
433.95
0.17%
-0.495
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$434.45
Offen:
$434.01
24-Stunden-Volumen:
699.75K
Relative Volume:
0.64
Marktkapitalisierung:
$96.55B
Einnahmen:
$76.39B
Nettoeinkommen (Verlust:
$7.81B
KGV:
14.92
EPS:
29.0772
Netto-Cashflow:
$7.93B
1W Leistung:
+0.29%
1M Leistung:
-8.65%
6M Leistung:
-5.65%
1J Leistung:
+26.43%
1-Tages-Spanne:
$431.67
$441.64
1-Wochen-Bereich:
$426.70
$452.39
52-Wochen-Spanne:
$330.00
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, FMS, ENSG, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
433.93 | 96.10B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
183.37 | 15.55B | 21.46B | 2.65B | 3.32B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.50 | 12.30B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
183.82 | 11.00B | 5.06B | 344.26M | 370.71M | 5.8446 |
EHC
Encompass Health Corp
|
107.42 | 10.11B | 5.94B | 758.60M | 439.20M | 5.5418 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
HCA Florida Healthcare urologist discusses treatments for kidney stones - WEAR-tv
HCA confirms limited number of layoffs - Nashville Post
New York State Teachers Retirement System Trims Stake in HCA Healthcare, Inc. $HCA - MarketBeat
State of New Jersey Common Pension Fund D Cuts Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
Danske Bank A S Grows Stock Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare, Inc. $HCA Shares Bought by Citizens Financial Group Inc. RI - MarketBeat
HCA SEC FilingsHca Healthcare Inc 10-K, 10-Q, 8-K Forms - Stock Titan
The 5 Most Interesting Analyst Questions From HCA Healthcare’s Q1 Earnings Call - TradingView
HCA SWOT Analysis: Strong Financial Performance Revealed in 10-Q Filing - GuruFocus
HCA Healthcare confirms layoffs - The Business Journals
Director Frist (NYSE: HCA) gets 809 RSUs, retains large indirect stake - Stock Titan
Thomas F. Frist III (HCA) granted 1,041 restricted share units as director pay - Stock Titan
Andrea Smith of HCA (NYSE: HCA) receives 509-share director equity award - Stock Titan
HCA (HCA) director Wayne Riley receives 509 restricted share units as equity award - Stock Titan
HCA Healthcare (NYSE: HCA) director receives 925-share equity award grant - Stock Titan
HCA Healthcare (NYSE: HCA) director granted 809 restricted share units - Stock Titan
Director at HCA Healthcare (NYSE: HCA) granted 509 RSUs - Stock Titan
HCA Healthcare (NYSE: HCA) director Chidsey granted 809 restricted share units - Stock Titan
HCA Healthcare Completes $3 Billion Senior Notes Offering - TipRanks
RBC Healthcare Conference to feature HCA on May 20 at 11:30 a.m. ET - Stock Titan
HCA Healthcare, Inc. to Present at May Conference - The Joplin Globe
[8-K] HCA Healthcare, Inc. Reports Material Event - Stock Titan
Tenet Healthcare Blames Admissions Mix For Soft Q1 Sales - Benzinga
HCA Healthcare (HCA) Announces Results of Annual Stockholders Me - GuruFocus
Vanguard Capital Management holds 11.7M HCA shares (NYSE: HCA) - Stock Titan
HCA opens downtown Orlando's first freestanding ER - The Business Journals
HCA Healthcare Stock (US40412C1018): Q1 2026 Earnings Release Expected Today - AD HOC NEWS
HCA Healthcare (HCA): A Target Cut, But Execution Still Gets Credit - Insider Monkey
HCA Healthcare (NYSE: HCA) lifts Q1 2026 revenue and EPS to $7.15 - Stock Titan
Is HCA Healthcare Stock Undervalued Stock Or Value Trap? - Trefis
Wealthfront Advisers LLC Purchases 8,463 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare Names Cynthia Cifuentes-Finkel Senior Vice President of Marketing and Corporate Affairs - Florida Hospital News and Healthcare Report
HCA Announces Proposed Public Offering of Senior Notes - Florida Hospital News and Healthcare Report
HCA Healthcare, Inc. $HCA Shares Purchased by Narwhal Capital Management - MarketBeat
Pictet Asset Management Holding SA Sells 16,605 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Has $40.27 Million Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
Comerica Bank Sells 3,248 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
This Week's Healthcare Earnings: Elevance, HCA And More - Law360
HCA Healthcare Stockholders Reaffirm Board and Governance Structure - TipRanks
HCA Healthcare Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
HCA Healthcare (HCA) shareholders elect directors, back pay plan, reject proposals - Stock Titan
HCA Healthcare Inc Stock (HCA) Closed Down by 3.23% on Apr 28: Drivers Behind the Movement - TradingKey
Congress grills hospital CEOs over costs - Modern Healthcare
HCA Healthcare beats quarterly profit estimates on medical care demand - MSN
HCA Healthcare posts $19.1B in revenue after setbacks from storm, lower ER volumes - The Business Journals
HCA Healthcare Inc. stock underperforms Friday when compared to competitors - MSN
Bernstein SocGen cuts HCA Healthcare price target on weather headwinds - Investing.com
Sanford C. Bernstein Lowers HCA Healthcare (NYSE:HCA) Price Target to $503.00 - MarketBeat
Deutsche Bank Aktiengesellschaft Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat
Deutsche Bank Adjusts HCA Healthcare Price Target to $540 From $558, Maintains Buy Rating - marketscreener.com
HCA DCF Analysis: Intrinsic Value $765 vs Price $446 - GuruFocus
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Hca Healthcare Inc-Aktie (HCA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| McAlevey Michael R | EVP & Chief Legal & Admin Off. |
Feb 18 '26 |
Sale |
533.37 |
1,694 |
903,537 |
8,853 |
3.35%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):